Count | |
| 9 | |
| 7 | |
| 2 | |
| 10 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 15 | |
| 1 | |
| 10 | |
| 1 | |
| 1 | |
| 7 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 8 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
Carcinoma in Situ/complications/immunology/pathology/*virology | 1 |
| 1 | |
| 1 | |
| 1 | |
Carcinoma in Situ/*complications/epidemiology/pathology/virology | 1 |
| 1 | |
| 1 | |
| 1 | |
| 6 | |
| 5 | |
| 2 | |
| 20 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 9 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 12 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |